CNTB vs. CTMX
Compare and contrast key facts about Connect Biopharma Holdings Limited (CNTB) and CytomX Therapeutics, Inc. (CTMX).
Performance
CNTB vs. CTMX - Performance Comparison
Loading graphics...
CNTB vs. CTMX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CNTB Connect Biopharma Holdings Limited | -7.09% | 41.71% |
CTMX CytomX Therapeutics, Inc. | 10.33% | 100.94% |
Fundamentals
CNTB:
$145.40M
CTMX:
$799.88M
CNTB:
-$1.03
CTMX:
-$0.11
CNTB:
5.58
CTMX:
9.55
CNTB:
2.04
CTMX:
8.08
CNTB:
$26.08M
CTMX:
$76.20M
CNTB:
$24.93M
CTMX:
$75.69M
CNTB:
-$56.30M
CTMX:
-$19.39M
Returns By Period
In the year-to-date period, CNTB achieves a -7.09% return, which is significantly lower than CTMX's 10.33% return.
CNTB
- 1D
- -9.66%
- 1M
- 6.07%
- YTD
- -7.09%
- 6M
- 73.51%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CTMX
- 1D
- 6.58%
- 1M
- -12.48%
- YTD
- 10.33%
- 6M
- 47.34%
- 1Y
- 639.23%
- 3Y*
- 46.01%
- 5Y*
- -9.80%
- 10Y*
- -9.91%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CNTB vs. CTMX — Risk / Return Rank
CNTB
CTMX
CNTB vs. CTMX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Connect Biopharma Holdings Limited (CNTB) and CytomX Therapeutics, Inc. (CTMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading graphics...
Sharpe Ratios by Period
| CNTB | CTMX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 3.81 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.07 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.09 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.62 | -0.08 | +0.70 |
Correlation
The correlation between CNTB and CTMX is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
CNTB vs. CTMX - Dividend Comparison
Neither CNTB nor CTMX has paid dividends to shareholders.
Drawdowns
CNTB vs. CTMX - Drawdown Comparison
The maximum CNTB drawdown since its inception was -33.81%, smaller than the maximum CTMX drawdown of -98.74%. Use the drawdown chart below to compare losses from any high point for CNTB and CTMX.
Loading graphics...
Drawdown Indicators
| CNTB | CTMX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -33.81% | -98.74% | +64.93% |
Max Drawdown (1Y)Largest decline over 1 year | — | -41.14% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -95.65% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -98.74% | — |
Current DrawdownCurrent decline from peak | -29.00% | -86.27% | +57.27% |
Average DrawdownAverage peak-to-trough decline | -17.10% | -70.40% | +53.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 17.69% | — |
Volatility
CNTB vs. CTMX - Volatility Comparison
Loading graphics...
Volatility by Period
| CNTB | CTMX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 53.47% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 74.27% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 100.81% | 169.33% | -68.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 100.81% | 142.15% | -41.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 100.81% | 111.35% | -10.54% |
Financials
CNTB vs. CTMX - Financials Comparison
This section allows you to compare key financial metrics between Connect Biopharma Holdings Limited and CytomX Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities